ProvayBlue injection, 50 mg/10 ml (5 mg/ml) had a market value of approximately $19 million for the 12 months ending April ...
In January 2026, Samsung Bioepis announced that the company signed a settlement and license agreement with Regeneron and Bayer concerning the commercialization of its biosimilar to Eylea 2 mg ...
Mumbai: Glenmark Pharmaceuticals Inc., USA has announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) ...
The FDA approved a regimen of one maintenance dose every 8 weeks for lebrikizumab-lbkz in adults and children aged 12 years and older who weigh at least 88 pounds with moderate to severe atopic ...
Glenmark Pharmaceuticals Inc., USA announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s Methylene Blue Injection USP is bioequivalent and ...
Injections deliver liquid medications, fluids, or nutrients directly into a person’s body. Different types of injections include intravenous, intramuscular, subcutaneous, intraosseous, and intradermal ...
The regulator has also revised prices of anti-tetanus immunoglobulin and three key childhood vaccines to ensure their continued availability. The decision, for which a gazette notification has been ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single Dose Vial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results